Skip to main content
Clinical Trials/NCT04629014
NCT04629014
Recruiting
Not Applicable

Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure

Boston Children's Hospital14 sites in 2 countries750 target enrollmentFebruary 27, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pediatric Intestinal Failure
Sponsor
Boston Children's Hospital
Enrollment
750
Locations
14
Primary Endpoint
Health-related quality of life (hrQOL)
Status
Recruiting
Last Updated
last month

Overview

Brief Summary

This study proposes to quantify and describe the quality of life of children with intestinal failure, and to identify the medical and socio-economic factors that impact this quality of life, using data from multiple multidisciplinary intestinal failure centers across the United States and Canada specializing in the care of these participants.

Detailed Description

Health related quality of life is becoming an increasingly important topic as medical advancements continue to increase life expectancies in various illnesses. Quality of life (QoL) encompasses the physical, psychological, and social well-being of a person. Studies focusing on health related QoL show that providers have a limited understanding of the QoL of their patients, demonstrating a need for further research. Mortality rates in pediatric intestinal failure (PIF) have significantly dropped over the past 3-4 decades and long-term morbidity rather than survival has come into focus as the outcome of interest. However, there remains a significant knowledge gap regarding the specific factors that contribute to QoL among PIF patients and their families. Insight into the challenges these patients face can promote enhanced support services and psycho-education for caregivers of these children as well as help to tailor medical and surgical treatment with a focus on improved QoL. Due to the rare nature of PIF, and despite a recent bloom in multidisciplinary PIF centers, experience is limited in individual centers and a multi-site study with a robust and diverse patient population is optimal to study QoL in pediatric intestinal failure.

Registry
clinicaltrials.gov
Start Date
February 27, 2020
End Date
December 1, 2029
Last Updated
last month
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Biren Modi

Surgical Director, Center for Advanced Intestinal Rehabilitation

Boston Children's Hospital

Eligibility Criteria

Inclusion Criteria

  • Participants will be followed in a participating institution's intestinal rehabilitation program
  • Participants will have a diagnosis of intestinal failure due to functional or structural intestinal dysfunction with current or prior history of specialized nutritional support (parenteral nutrition requirement for 60 out of 74 consecutive days)
  • Participants will be age 6 months to 25 years old.
  • Parents/caregivers must be able to complete questionnaire without assistance.
  • English or Spanish speaking

Exclusion Criteria

  • Participants aged less than 6 months or greater than 25 years will not be included in this study
  • Participants will not be enrolled less than 3 months from index admission or initial outpatient evaluation
  • Participants will not be enrolled less than 1 month from inpatient admission (any admission greater than 24 hours in duration)
  • Participants will not be enrolled less than 1 month from any operative intervention requiring general anesthesia.
  • Primary language other than English or Spanish.
  • Participants who have a currently functional small bowel, liver/small bowel or multivisceral transplant
  • While other major co-morbidities may be excluded at a later time during data analysis, or may be analyzed as a specific sub-group, they will not be excluded outright. For example, participants with global developmental delay may have parent surveys only, and therefore would need to be excluded from paired analysis of proxy vs. participant perception of HRQOL

Outcomes

Primary Outcomes

Health-related quality of life (hrQOL)

Time Frame: Baseline

hrQOL as determined by PedsQL Generic Core at time of enrollment and corrected for time from onset of disease

Health-related quality of life (hrQOL) Change over time

Time Frame: Trend over 5 years

hrQOL as determined by PedsQL Generic Core, assessed annually, looking at trend in change over 5 years of assessment and corrected for time from onset of disease

Disease-specific Health-related quality of life (hrQOL)

Time Frame: Trend over 5 years

Disease-specific hrQOL as determined by PedsQL GI Symptoms Scale, assessed annually, looking at trend in change over 5 years of assessment and corrected for time from onset of disease

Disease-specific Health-related quality of life (hrQOL)

Time Frame: Baseline

Disease-specific hrQOL as determined by PedsQL GI Symptoms Scale at time of enrollment and corrected for time from onset of disease

Secondary Outcomes

  • Family Impact(Trend over 5 years)
  • Family Impact(Baseline)

Study Sites (14)

Loading locations...

Similar Trials